Aug 14, 2025, 12:00 AM
Serum metabolome serves as diagnostic biomarker and discriminates patients with melanoma from healthy individuals
Melanoma is a deadly cancer with increasing incidence and mortality rates, and biomarkers for diagnosis are urgently needed. The impact of the microbiome, genetic factors, and immunologic markers on d…
Review of immune checkpoint inhibitors in non-melanoma malignancies
Over the last decade, immune checkpoint inhibitors (ICIs) have been established as an integral component of the contemporary anticancer armamentarium. In dermatology, ICIs are most established as trea…
Read more about 'Review of immune checkpoint inhibitors in non-melanoma malignancies'...
CtDNA detection after surgery can identify melanoma patients with worse prognosis
Background: Locally advanced melanoma has a variable prognosis. Currently, there are no reliable criteria to stratify the risk of disease relapse and identify those patients who will benefit the most …
Therapeutic approaches to mucosal melanoma
Mucosal melanoma (MM) is a rare and aggressive subtype of melanoma arising from mucosal tissues, with distinct genomic and clinical characteristics compared with cutaneous melanoma (CM). Despite thera…
Read more about 'Therapeutic approaches to mucosal melanoma'...